We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ThromboGenics Receives Positive CHMP Opinion for JETREA®

News   Apr 24, 2013

 
ThromboGenics Receives Positive CHMP Opinion for JETREA®
 
 
 

RELATED ARTICLES

Building Biologically Active Compounds Using Light

News

Researchers have now published a new method for building 3D scaffolds from flat aromatics using a photocatalyst.

READ MORE

Compound Targets Previously “Undruggable” STAT3 To Combat Cancer

News

A compound has been developed that targets transcription factor STAT3, offering a new approach to a previously “undruggable” target.

READ MORE

GW Pharmaceuticals Receives Positive NICE Recommendation for EPIDYOLEX (Cannabidiol)

News

GW Pharmaceuticals plc announces that two of its medicines, EPIDYOLEX (cannabidiol) oral solution and Sativex (nabiximols), have been recommended by the UK’s National Institute for Health and Care Excellence (NICE) to receive routine reimbursement from NHS England.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE